Healthcare

Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc­ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.

A deficit in healthcare and its skewed availability across states remain major limitations.

The government continues ignoring the increasing demand for health services and the shortage of doctors.

Though the global spending on health is rising worldwide, people were still paying too much out of their pockets. This article examined the comparative expenditure on hospitalised care in India using three rounds of the National Sample Surveys. As there is low footfall in public facilities, the Government of India needs to take necessary measures to strengthen the public health system.

The appropriateness of the criterion that pegs the ratio of public health expenditure to the gross domestic product—which is volatile—needs a re-examination. The targets for allocation and expenditure of financial resources for health need to be based on indicators that can be monitored.